Navigation Links
NYU researchers develop compound to block signaling of cancer-causing protein
Date:7/17/2011

Researchers at New York University's Department of Chemistry and NYU Langone Medical Center have developed a compound that blocks signaling from a protein implicated in many types of cancer. The compound is described in the latest issue of the journal Nature Chemical Biology.

The researchers examined signaling by receptor tyrosine kinase (RTK). Abnormal RTK signaling is a major underlying cause of various developmental disorders and diseases, including many forms of cancer. RTK signaling pathway employs interactions between proteins Sos and Ras, and accounts for a broad range of molecular changes that underlie various cancers and other diseases. Disrupting the Sos-Ras interaction, then, is crucial to stemming the production of cancer cells.

However, interactions between large protein molecules such as Ras and Sos have been difficult to modulate with artificial means. Through a series of experimental and computational analyses, the scientists hypothesized that by mimicking a key portion of Sos, they might disrupt its interactions with Ras. Specifically, they observed that Sos activates Ras through a helixa critical portion of Sos that makes contact with Ras. Creation of this Sos mimetic required a method for locking correct helical shapes in synthetic strings of amino acids a method previously developed at NYU School of Medicine.


'/>"/>

Contact: James Devitt
james.devitt@nyu.edu
212-998-6808
New York University
Source:Eurekalert

Page: 1

Related medicine news :

1. Mayo researchers: Genetic mutation linked to Parkinsons disease
2. Researchers Closer to Developing Universal Meningitis B Vaccine
3. Novel Virus Jumped From Monkeys to Humans, Researchers Find
4. Dentists can identify people with undiagnosed diabetes, Columbia researchers show
5. UAB researchers present a study on the psychological adaptation of adopted children
6. Researchers identify key role of microRNAs in melanoma metastasis
7. A change of heart: Penn researchers reprogram brain cells to become heart cells
8. Researchers identify early biomarker for future atopy in asymptomatic children
9. Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography
10. Leeds researchers test benefit of fish oil in bowel cancer spread
11. Fox Chase researchers identify new mechanism used by cells to reverse silenced genes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics this week announced the launch ... mounts ever. , “Our goal was to develop a product from the ground ... we have ever created.” said Darren Hulsey, Product Manager for Workrite Ergonomics. “The ...
(Date:2/10/2016)... ... ... The recreational use of marijuana has been legal in Colorado for over ... restrictions as to where they can smoke pot. , As Colorado’s website ... not be consumed openly or publicly.” , Given the momentum of the marijuana legalization ...
(Date:2/10/2016)... , ... February 09, 2016 , ... A new leadership ... Summer 2016. FHU President Joe Wiley made the announcement Monday night, Feb. 8, prior ... a 2003 graduate of FHU and the creator of GO! Camp, has been named ...
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. ... are delighted to welcome a new addition to their growing practice. Beginning this ... as a nurse practitioner performing cosmetic procedures including injectables, fillers and ...
(Date:2/10/2016)... , ... February 09, 2016 , ... ... concussion, yet the cause of injury may be one of many possible sources: ... PT Continuing Education Course , Mastering Rehab Solutions for the Complexities ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 10, 2016 ... and M 1 receptor selectivity   ... StaR® technology, which has entered clinical development as ... with dementia and schizophrenia.   --> ... technology, which has entered clinical development as a ...
(Date:2/9/2016)... -- Landauer, Inc. (NYSE: LDR ), a recognized leader ... medical physics services and high quality medical consumable accessories, ... quarter ended December 31, 2015. ... Highlights , Revenue of $36.5 million compared to ... Domestic Radiation Measurement services revenues increased 2.8% year-over-year ...
(Date:2/9/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... its fourth quarter and full year 2015 financial ... therapeutic genome editing," said Edward Lanphier, Sangamo,s president ... (ZFN) technology leads the therapeutic genome editing field ... to move our ground-breaking genome editing programs through ...
Breaking Medicine Technology: